Greenwood Capital Associates’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CYRX
CCM
BCM
FAM
TAM
Greenwood Capital Associates's CYRX Position: Q1 2025 in Review
Greenwood Capital Associates sold out of CryoPort (CYRX) in Q1 2025, closing a stake of 67,234 shares — an estimated $523K sold.
Greenwood Capital Associates first reported a position in CYRX in Q2 2018 and held it in 27 quarters. The position peaked at $1.92M in Q3 2021. 153 funds tracked by Wall St. Rank hold CYRX as of Q1 2025.
- Greenwood Capital Associates reported no remaining CryoPort position as of Q1 2025 after selling out during the quarter.
- Greenwood Capital Associates sold 67,234 CryoPort shares in Q1 2025, an estimated $523K.
- Greenwood Capital Associates first reported a position in CryoPort in Q2 2018 and held it in 27 quarters.
- Greenwood Capital Associates's CryoPort position peaked at $1.92M in Q3 2021.
- 153 funds tracked by Wall St. Rank held CryoPort as of Q1 2025.
Based on Greenwood Capital Associates's 13F filing for Q1 2025, filed 15 Apr 2025.